These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. [Use of intravenous immunoglobulin in treatment of neoplasms and hematologic disorders in children]. Wróbel G; Chybicka A; Kazanowska B Postepy Hig Med Dosw; 2002; 56 Suppl():59-68. PubMed ID: 12661416 [TBL] [Abstract][Full Text] [Related]
30. Intravenous immune globulin in chronic lymphocytic leukaemia. Gamm H; Huber C; Chapel H; Lee M; Ries F; Dicato MA Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):17-20. PubMed ID: 8033428 [TBL] [Abstract][Full Text] [Related]
31. [Effects of immunoglobulin (Intraglobin) on tendency toward infection in chronic lymphatic leukemia]. Hovgaard D; Hansen MM Ugeskr Laeger; 1987 Nov; 149(46):3097-9. PubMed ID: 3127974 [No Abstract] [Full Text] [Related]
32. Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome. Danieli MG; Cappelli M; Malcangi G; Logullo F; Salvi A; Danieli G Ann Rheum Dis; 2004 Dec; 63(12):1649-54. PubMed ID: 15547090 [TBL] [Abstract][Full Text] [Related]
33. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655 [TBL] [Abstract][Full Text] [Related]
34. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. Lucas M; Lee M; Lortan J; Lopez-Granados E; Misbah S; Chapel H J Allergy Clin Immunol; 2010 Jun; 125(6):1354-1360.e4. PubMed ID: 20471071 [TBL] [Abstract][Full Text] [Related]
35. [Intravenously applied immunoglobulin in systemic, autoimmune and vasculitis diseases in children]. Zeman K; Cywińska-Bernas A Pol Merkur Lekarski; 2011 Jun; 30(180):400-4. PubMed ID: 21751547 [TBL] [Abstract][Full Text] [Related]
36. Cerebral haemorrhage in a patient with systemic lupus erythematosus and vasculitis treated with intravenous immunoglobulins for a long-time and in absence of other risk factors. Giannitti C; Cerase A; Miracco C; Fioravanti A Clin Ter; 2011; 162(2):125-7. PubMed ID: 21533318 [TBL] [Abstract][Full Text] [Related]
37. Intravenous immunoglobulin replacement prevents severe and lower respiratory tract infections, but not upper respiratory tract and non-respiratory infections in common variable immune deficiency. Favre O; Leimgruber A; Nicole A; Spertini F Allergy; 2005 Mar; 60(3):385-90. PubMed ID: 15679727 [TBL] [Abstract][Full Text] [Related]
38. Intravenous immunoglobulins as treatment of severe cutaneous polyarteritis nodosa. Marie I; Miranda S; Girszyn N; Soubrane JC; Vandhuick T; Levesque H Intern Med J; 2012 Apr; 42(4):459-62. PubMed ID: 22498120 [TBL] [Abstract][Full Text] [Related]